{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011770","form_type":"8-K","ticker":"DMRA","cik":"0001800315","company_name":"Damora Therapeutics, Inc.","filed_at":"2022-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.363085+00:00","generated_at":"2026-06-25T00:57:41.482770+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Galecto stockholders elect two Class II directors and ratify auditor at 2022 annual meeting","bullets":["Carl Goldfischer, M.D. elected with 11,025,408 votes for; David Shapiro, M.D. with 11,050,440 votes for.","Ratification of EY Godkendt Revisionspartnerselskab as independent auditor for FY2022: 15,589,293 for, 33,022 against.","15,647,815 shares represented at meeting out of 25,261,832 entitled to vote; 3,360,631 broker non-votes on director election."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011770","json":"https://secwatch.observer/filing/0000950170-22-011770.json","markdown":"https://secwatch.observer/filing/0000950170-22-011770.md","text":"https://secwatch.observer/filing/0000950170-22-011770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800315/000095017022011770/0000950170-22-011770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800315/000095017022011770/glto-20220614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:57:41.482770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}